✦ LIBER ✦

High-frequency low-dose multiple-drug chemotherapy in advanced metastatic breast cancer

✍ Scribed by Arthur Berken; Michael N. Greenblatt; David S. Rosenthal; Gilbert Graham

Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 285 KB
Volume: 49
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19820601)49:11<2231::aid-cncr2820491105>3.0.co;2-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose, multiple-alkylator chemothera

High-dose, multiple-alkylator chemotherapy with autologous bone marrow reinfusion in patients with advanced non-small cell lung cancer

✍ Stephanie F. Williams; Jacob D. Bitran; Philip C. Hoffman; Erwin Robin; Laura Fu 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 2 views

Comparison of four-combination chemother

Comparison of four-combination chemotherapy programs in metastatic breast cancer. Comparison of multiple drug therapy with cytoxan, 5-fu and prednisone versus cytoxan and adriamycin, versus cytoxan, 5-Fu and adriamycin, versus cytoxan, 5-Fu and prednisone alternating with cytoxan and adriamycin

✍ Takuma Nemoto; John Horton; Richard Simon; Thomas L. Dao; Dutzu Rosner; Thomas C 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB 👁 2 views

In 126 postmenopausal women with metastatic breast cancer, four chemotherapeutic combination programs were tested. Patients were stratified and randomized to one o f the four programs: (1) fluorouracil, cytoxan and prednisone (CFP): (2) fluorouracil, cytoxan and Adriamycin (CAF); (3) cytoxan and Adr